FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2317142829> ?p ?o ?g. }

• W2317142829 endingPage "e29" @default.
• W2317142829 startingPage "e20" @default.
• W2317142829 abstract "Elevated serum levels of high-sensitive C-reactive protein (hs-CRP) and total cholesterol (TC) correlate with atherosclerotic vascular disease and increased frequency of vascular events. In this study, we investigated the effect of atorvastatin treatment on serum hs-CRP and TC levels, and the recurrence rate of atrial fibrillation (AF) in patients. Furthermore, a meta-analysis was performed to confirm the findings in this study. A total of 105 patients with AF were recruited to this study, including 55 patients with AF who were treated with amiodarone and atorvastatin (the treatment group) and 50 patients with AF who were treated with only amiodarone (the control group). Patients were treated for 12 months and followed up regularly for 1 year. Serum hs-CRP and TC levels in patients before and after treatment were recorded, and AF recurrence rate at 3, 6, and 12 months of treatment was obtained. Statistical analyses were performed with R 3.1.0 software and STATA 12.0 software. For patients in both treatment and control groups, serum hs-CRP and TC levels were high before the treatments began (both P < 0.05). However, after 12 months of treatment, serum hs-CRP and TC levels in the treatment group was dramatically reduced compared with the control group (hs-CRP: 3.63 ± 2.14 mg/L vs. 2.75 ± 1.89 mg/L, t = 2.24, P = 0.027; TC: 4.66 ± 1.13 mmol/L vs. 4.20 ± 1.06 mmol/L, t = 2.15, P = 0.034). After 12 months of treatment, the AF recurrence rate in the treatment group was significantly lower than the control group (16.4% vs. 34.0%; χ 2 = 4.37; P = 0.037). In addition, 13 studies were selected for meta-analysis. Pooled results of the meta-analysis showed that serum hs-CRP and TC levels decreased significantly in the treatment group compared with the case group [hs-CRP: SMD = 0.95, 95% confidence interval (CI) = 0.62–1.29, and P < 0.001; TC: SMD = 1.39, 95% CI = 0.65–2.13, and P < 0.001]. Our study presents compelling evidence that atorvastatin is highly effective in reducing serum hs-CRP and TC levels and lowering the recurrence rate of AF." @default.
• W2317142829 created "2016-06-24" @default.
• W2317142829 creator A5007399611 @default.
• W2317142829 creator A5037677450 @default.
• W2317142829 creator A5051680566 @default.
• W2317142829 creator A5073651150 @default.
• W2317142829 date "2017-01-01" @default.
• W2317142829 modified "2023-09-26" @default.
• W2317142829 title "Effects of Atorvastatin on Serum High-Sensitive C-Reactive Protein and Total Cholesterol Levels in Asian Patients With Atrial Fibrillation" @default.
• W2317142829 cites W101847764 @default.
• W2317142829 cites W1972142091 @default.
• W2317142829 cites W1975210253 @default.
• W2317142829 cites W1983199352 @default.
• W2317142829 cites W1984574215 @default.
• W2317142829 cites W1985922981 @default.
• W2317142829 cites W1986540185 @default.
• W2317142829 cites W1988604278 @default.
• W2317142829 cites W1994315223 @default.
• W2317142829 cites W2000344118 @default.
• W2317142829 cites W2001423032 @default.
• W2317142829 cites W2006592697 @default.
• W2317142829 cites W2012644487 @default.
• W2317142829 cites W2022007723 @default.
• W2317142829 cites W2027493276 @default.
• W2317142829 cites W2033883716 @default.
• W2317142829 cites W2046590737 @default.
• W2317142829 cites W2051678731 @default.
• W2317142829 cites W2055903746 @default.
• W2317142829 cites W2057550630 @default.
• W2317142829 cites W2062009962 @default.
• W2317142829 cites W2062449826 @default.
• W2317142829 cites W2066764874 @default.
• W2317142829 cites W2070489918 @default.
• W2317142829 cites W2076036857 @default.
• W2317142829 cites W2080394959 @default.
• W2317142829 cites W2081232925 @default.
• W2317142829 cites W2092336097 @default.
• W2317142829 cites W2107020336 @default.
• W2317142829 cites W2113279029 @default.
• W2317142829 cites W2134852288 @default.
• W2317142829 cites W2137983259 @default.
• W2317142829 cites W2139245232 @default.
• W2317142829 cites W2147918774 @default.
• W2317142829 cites W2168685024 @default.
• W2317142829 cites W2170737858 @default.
• W2317142829 cites W2320342665 @default.
• W2317142829 cites W4211249670 @default.
• W2317142829 doi "https://doi.org/10.1097/mjt.0000000000000344" @default.
• W2317142829 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26566148" @default.
• W2317142829 hasPublicationYear "2017" @default.
• W2317142829 type Work @default.
• W2317142829 sameAs 2317142829 @default.
• W2317142829 citedByCount "6" @default.
• W2317142829 countsByYear W23171428292016 @default.
• W2317142829 countsByYear W23171428292017 @default.
• W2317142829 countsByYear W23171428292020 @default.
• W2317142829 countsByYear W23171428292021 @default.
• W2317142829 crossrefType "journal-article" @default.
• W2317142829 hasAuthorship W2317142829A5007399611 @default.
• W2317142829 hasAuthorship W2317142829A5037677450 @default.
• W2317142829 hasAuthorship W2317142829A5051680566 @default.
• W2317142829 hasAuthorship W2317142829A5073651150 @default.
• W2317142829 hasConcept C126322002 @default.
• W2317142829 hasConcept C134018914 @default.
• W2317142829 hasConcept C2776914184 @default.
• W2317142829 hasConcept C2777482532 @default.
• W2317142829 hasConcept C2778094803 @default.
• W2317142829 hasConcept C2778163477 @default.
• W2317142829 hasConcept C2779161974 @default.
• W2317142829 hasConcept C2781195455 @default.
• W2317142829 hasConcept C71924100 @default.
• W2317142829 hasConcept C90924648 @default.
• W2317142829 hasConceptScore W2317142829C126322002 @default.
• W2317142829 hasConceptScore W2317142829C134018914 @default.
• W2317142829 hasConceptScore W2317142829C2776914184 @default.
• W2317142829 hasConceptScore W2317142829C2777482532 @default.
• W2317142829 hasConceptScore W2317142829C2778094803 @default.
• W2317142829 hasConceptScore W2317142829C2778163477 @default.
• W2317142829 hasConceptScore W2317142829C2779161974 @default.
• W2317142829 hasConceptScore W2317142829C2781195455 @default.
• W2317142829 hasConceptScore W2317142829C71924100 @default.
• W2317142829 hasConceptScore W2317142829C90924648 @default.
• W2317142829 hasIssue "1" @default.
• W2317142829 hasLocation W23171428291 @default.
• W2317142829 hasLocation W23171428292 @default.
• W2317142829 hasOpenAccess W2317142829 @default.
• W2317142829 hasPrimaryLocation W23171428291 @default.
• W2317142829 hasRelatedWork W1966504330 @default.
• W2317142829 hasRelatedWork W1967841144 @default.
• W2317142829 hasRelatedWork W1979139803 @default.
• W2317142829 hasRelatedWork W2035331946 @default.
• W2317142829 hasRelatedWork W2037631372 @default.
• W2317142829 hasRelatedWork W2040058909 @default.
• W2317142829 hasRelatedWork W2116219847 @default.
• W2317142829 hasRelatedWork W2317142829 @default.
• W2317142829 hasRelatedWork W2360585662 @default.
• W2317142829 hasRelatedWork W2748952813 @default.
• W2317142829 hasVolume "24" @default.

• next